Navigation Links
Scientists Identify Inherited Prostate Cancer Gene
Date:1/11/2012

WEDNESDAY, Jan. 11 (HealthDay News) -- The first major gene mutation associated with an increased risk for hereditary prostate cancer has been identified by scientists.

Men who inherit the mutation in the HOXB13 gene have a 10 to 20 times increased risk of developing prostate cancer, according to the study in the Jan. 12 issue of the New England Journal of Medicine.

The HOXB13 gene plays an important role in the development of the prostate during the fetal stage and in prostate function later in life.

The discovery of this gene mutation may help improve understanding about the development of prostate cancer and which men may require early screening for the disease, according to the team led by investigators at the Johns Hopkins University School of Medicine and the University of Michigan Health System.

The researchers analyzed DNA from the youngest prostate cancer patients in 94 families that had multiple cases of the disease among close relatives, such as fathers, sons and brothers. Members of four different families were found to have the same mutation in the HOXB13 gene. All 18 patients in those four families had the mutation.

The investigators then looked at 5,100 men who had been treated for prostate cancer and found that 1.4 percent (72) of them had the same HOXB13 gene mutation. The men with the mutation were much more likely to have at least one first-degree male relative (father or brother) who also had been diagnosed with prostate cancer.

When they looked at a control group of 1,400 men without prostate cancer, the study authors found that only one of the men had the mutation.

The researchers also looked at data from men enrolled in studies of early-onset or familial prostate cancer.

"We found that the mutation was significantly more common in men with a family history and early diagnosis compared with men diagnosed later, after age 55, without a family history. The difference was 3.1 percent versus 0.62 percent," Dr. Kathleen Cooney, a professor of internal medicine and urology at the University of Michigan Medical School, and one of the study's two senior authors, said in a Hopkins news release.

"It's what we've been looking for over the past 20 years," added fellow senior author William Isaacs, a professor of urology and oncology at the Johns Hopkins University School of Medicine. "It's long been clear that prostate cancer can run in families, but pinpointing the underlying genetic basis has been challenging and previous studies have provided inconsistent results."

An estimated 240,000 men in the United States will be diagnosed with prostate cancer this year. While the HOXB13 gene mutation may account for only a small number of prostate cancer cases, it may provide clues about how this cancer develops and help to identify a group of men who might benefit from early or additional prostate cancer screening, the researchers said.

More information

The American Cancer Society has more about prostate cancer.

-- Robert Preidt

SOURCE: Johns Hopkins Medicine, news release, Jan. 11, 2012


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Scientists Create First Monkeys With Mixed Genomes
2. Scientists reassess weight loss surgery for type 2 diabetes
3. Scientists crack medieval bone code
4. Scientists fixate on Ric-8 to understand trafficking of popular drug receptor targets
5. NOAA scientists: spilled oil unexpectedly lethal to fish embryos in shallow, sunlit waters
6. Rare brain disorder may be more common than thought, say Mayo Clinic scientists
7. Scientists Ponder Santas High-Tech Secrets
8. Scientists Probe the Origins of Dyslexia
9. UCLA neuroscientists demonstrate crucial advances in brain reading
10. Buildup of Newer Flame Retardants Concerns Scientists
11. NIH scientists find a potential new avenue for cancer therapies
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Scientists Identify Inherited Prostate Cancer Gene
(Date:12/8/2016)... ... December 08, 2016 , ... Coffey Agencies, a ... and commercial clients in the northern Alabama and Georgia regions, is embarking on ... 1977, Nobis Works has built a network of support and education facilities to ...
(Date:12/7/2016)... , ... December 07, 2016 , ... DrugDev ... announcement that it is one of the early adopters completing EU-U.S. Privacy Shield Certification ... designed to provide companies on both sides of the Atlantic with a mechanism to ...
(Date:12/7/2016)... (PRWEB) , ... December 07, 2016 , ... ... celebrating the passage of the most comprehensive mental health systems reform legislation in ... support of the President, and the commitment of our elected officials to improving ...
(Date:12/7/2016)... York, NY (PRWEB) , ... December 07, 2016 ... ... amounts of the drug in their bodies, a researcher at the Icahn School ... journal Pediatric Research. , The study found that when young children are exposed ...
(Date:12/7/2016)... ... December 07, 2016 , ... ... of Smart Device Remote Control through a new partnership with Splashtop Inc. This ... strengthens its mobile solutions to help businesses maximize their uptime and productivity. , ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... , Dec. 8, 2016 Henry Schein, Inc. (Nasdaq: ... care products and services to office-based dental, animal health and ... equity investment in Marrodent, one of Poland,s ... $32 million. This transaction was announced on August 30, 2016. ... Poland since 2014, and Marrodent marks ...
(Date:12/8/2016)... Dec 8, 2016 Research and Markets has announced ... report to their offering. ... , The report provides separate comprehensive ... , and Rest of World. Annual estimates and ... historic analysis is provided for these markets. Market data and analytics are ...
(Date:12/7/2016)... Dec. 7, 2016 "Lantus (Insulin Glargine) Biosimilar Clinical Trial & ... biosimilar version of Lantus drug in clinical pipeline. Currently 5 biosimilar version ... Japan , Kenya , Czech ... , China , Slovakia , ... 2 diabetes mellitus. The patent on Lantus expired in 2014. Lantus ...
Breaking Medicine Technology: